Akèy › Kansè tèt ak kou › Kentucky › Lexington
Etid klinik pou Kansè tèt ak kou nan Lexington, KY
4 etid pou Kansè tèt ak kou ap chèche patisipan nan sit nan ak bò kote Lexington (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
Ap rekriteFaz 2/3
- University of Kentucky, Markey Cancer Center (Site # 109), Lexington
Lead-212 PSV359 Therapy for Patients With Solid Tumors
Ap rekriteFaz 1/2
- University of Kentucky, Lexington
A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma
Ap rekriteFaz 3
- GSK Investigational Site, Lexington
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- Baptist Lexington, Lexington
Etid Kansè tèt ak kou nan lòt vil
- Houston, TX30 etid
- Boston, MA22 etid
- Nashville, TN21 etid
- New York City, NY21 etid
- St. Louis, MO15 etid
- Dallas, TX12 etid
- Pittsburgh, PA11 etid
- San Antonio, TX10 etid
- Los Angeles, CA10 etid
- Washington, DC10 etid
- Baltimore, MD10 etid
- Durham, NC10 etid
Lòt etid nan Lexington
- Kansè Poumon ki pa ti selil23 etid
- Kansè poumon18 etid
- Kansè ovè16 etid
- Kansè pwostat14 etid
- Kansè (tout kalite)14 etid
- Kansè nan tete14 etid
- Kansè Metastatik11 etid
- Kansè kolorektal11 etid
- Ensifizyans kadyak11 etid
- Melanom10 etid
- Leksemi mieloïd egi10 etid
- Obèsite10 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.